Skip to content

Author

Jesse C. Nussbaum

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

An open-label, Phase 1 study to evaluate the drug-drug interaction between ulonivirine and the combined oral contraceptive levonorgestrel/ethinyl estradiol in female participants without HIV

ABSTRACT Ulonivirine is a non-nucleoside reverse transcriptase inhibitor in development as an oral, once-weekly treatment for HIV-1 in combination with investigational islatravir. The effect of ulonivirine on the pharmacokinetics of an oral contraceptive, levonorgestrel (LNG)/ethinyl estradiol (EE) was evaluated in fem...

Makeda L. Robinson, Gillian Gillespie, Bhargava Kandala et al. · 0 citations
Open access Oct 2026

Open-label Phase 1 study to evaluate drug-drug interactions between ulonivirine and islatravir in adults without HIV

No clinically meaningful DDIs were observed between ulonivirine 200 mg and islatravir 2 mg, supporting continued development of this combination for HIV-1 treatment, and safety parameters were comparable among all three periods.

Jesse C. Nussbaum, Michelle M. Pham, R. Vargo et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.